Testing normality of fetal DNA concentration in maternal plasma at 10-12 completed weeks' gestation: A preliminary approach to a new marker for genetic screening

Prenatal Diagnosis

Volumn 22, Issue 2, 2002, Pages 148-152

  Farina, Antonio ^a   Caramelli, Elisabetta ^a   Concu, Manuela ^a   Sekizawa, Akihiko ^b   Ruggeri, Roberto ^a   Bovicelli, Luciano ^a   Rizzo, Nicola ^a   Carinci, Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Cell free fetal DNA; Down syndrome screening; Kolmogorov Smirnov test; Real time PCR

Indexed keywords

DNA;

ADULT; ARTICLE; BETA THALASSEMIA; CHORION VILLUS SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA CONTENT; DOWN SYNDROME; FEASIBILITY STUDY; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; KARYOTYPE; KOLMOGOROV SMIRNOV TEST; MALE; MATERNAL BLOOD; NORMAL HUMAN; NORMAL VALUE; POLYMERASE CHAIN REACTION; PRELIMINARY COMMUNICATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; Y CHROMOSOME;

BETA-THALASSEMIA; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; DNA; DOWN SYNDROME; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; KARYOTYPING; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 0036186050     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.262     Document Type: Article

References (21)

1. Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction
2. Fetal cells in the mother: From genetic diagnosis to diseases associated with fetal cell microchimerism
3. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies
4. Microsatellite alterations in plasma DNA of small cell lung cancer patients
5. Biochemical screening for Down syndrome
6. Fetal cells in maternal blood as a second non-invasive step for fetal Down syndrome screening
7. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia
8. Fetal DNA in maternal plasma
9. Fetal DNA in maternal plasma: Biology and diagnostic applications
10. Presence of fetal DNA in maternal plasma and serum
11. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
12. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21
13. Quantitation of fetal DNA in maternal serum in normal and aneuploid pregnancies
14. First trimester prenatal diagnosis: Fetal cells in the maternal circulation
15. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats
16. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood
17. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
18. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry
19. Advances in antenatal screening for Down syndrome
20. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters
21. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses